Tech Company Financing Transactions

Inflazome Funding Round

Inflazome, operating out of Dublin, secured $17 million in investment from Fountain Healthcare Partners, Novartis Venture Fund and private investors.

Transaction Overview

Company Name
Announced On
9/13/2016
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Series A
Investors

Fountain Healthcare Partners (Lead Investor) (Manus Rogan)

Novartis Venture Fund (Lead Investor) (Florent Gros)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
32 Kildare St.
Dublin, 2
Ireland
Email Address
Overview
We are dedicated to improving lives by delivering new medicines that stop inflammation. Our founders are globally acknowledged scientific leaders whose vision is to transition their work from the lab to life.
Profile
Inflazome LinkedIn Company Profile
Social Media
Inflazome Company Twitter Account
Company News
Inflazome News
Facebook
Inflazome on Facebook
YouTube
Inflazome on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Matthew Cooper
  Matthew Cooper LinkedIn Profile  Matthew Cooper Twitter Account  Matthew Cooper News  Matthew Cooper on Facebook
Chief Scientific Officer
Luke O'Neill
  Luke O'Neill LinkedIn Profile  Luke O'Neill Twitter Account  Luke O'Neill News  Luke O'Neill on Facebook
VP - Bus. Development
Jeremy Skillington
  Jeremy Skillington LinkedIn Profile  Jeremy Skillington Twitter Account  Jeremy Skillington News  Jeremy Skillington on Facebook
VP - Finance
Conor Dalton
  Conor Dalton LinkedIn Profile  Conor Dalton Twitter Account  Conor Dalton News  Conor Dalton on Facebook
VP - R & D
Angus MacLeod
  Angus MacLeod LinkedIn Profile  Angus MacLeod Twitter Account  Angus MacLeod News  Angus MacLeod on Facebook
VP - Regulatory Affairs
Joanna Tufnell
  Joanna Tufnell LinkedIn Profile  Joanna Tufnell Twitter Account  Joanna Tufnell News  Joanna Tufnell on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/13/2016: AcuFocus venture capital transaction
Next: 9/13/2016: Avitide venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary